Bristol buying out Axion stake in Oncology Therapeutics Network joint venture.
Executive Summary
BRISTOL TO BUY OUT ONCOLOGY THERAPEUTICS NETWORK JOINT VENTURE from co-owner Axion, a San Bruno, Calif.-based oncology specialty firm, BMS announced Aug. 5. Bristol-Myers Squibb bought a 50% interest in Oncology Therapeutics Network in 1993. Axion founded its physician-office oncology product distribution business in 1990.
You may also be interested in...
Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011